Interestingly, we noticed that the naïve subset had the lowest proportion of CD226+ cells compared to the other subsets in both CLL patients (Fig. 2G) and HCs (Fig. S1B). The gene discussed is CD226; the disease is B-cell chronic lymphocytic leukemia.